Skip to Main Content

Author Details

Michael Bockmayr
Institute of Pathology, Charite Universitatsmedizin Berlin
2013
40
18
PMIDPaper TitleJournal TitlePublished Year
37871132Toward Explainable Artificial Intelligence for Precision Pathology.Annu Rev Pathol2024
36629274Single-cell gene regulatory network prediction by explainable AI.Nucleic Acids Res2023
37569208Rapid Determination of Nutmeg Shell Content in Ground Nutmeg Using FT-NIR Spectroscopy and Machine Learning.Foods2023
37450044Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics.Acta Neuropathol2023
36715306Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups.Neuro Oncol2023
36866403Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities.Neuro Oncol2023
36459208Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts.Acta Neuropathol2023
34878655Machine learning models predict the primary sites of head and neck squamous cell carcinoma metastases based on DNA methylation.J Pathol2022
35380708Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing disease.Neuro Oncol2022
35672443Patient-level proteomic network prediction by explainable artificial intelligence.NPJ Precis Oncol2022
36443295DNA methylation-based classification of sinonasal tumors.Nat Commun2022
33631297Artificial intelligence and pathology: From principles to practice and future applications in histomorphology and molecular profiling.Semin Cancer Biol2022
35190934Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies.J Neurooncol2022
33331994Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.Acta Neuropathol2021
33768604Cauda equina paragangliomas express HOXB13.Neuropathol Appl Neurobiol2021
34235002DIMEimmune: Robust estimation of infiltrating lymphocytes in CNS tumors from DNA methylation profiles.Oncoimmunology2021
32286358Resolving challenges in deep learning-based analyses of histopathological images using explanation methods.Sci Rep2020
32603315Glioma escape signature and clonal development under immune pressure.J Clin Invest2020
32601356Multiclass cancer classification in fresh frozen and formalin-fixed paraffin-embedded tissue by DigiWest multiplex protein analysis.Lab Invest2020
32926213Molecular characterization of CNS paragangliomas identifies cauda equina paragangliomas as a distinct tumor entity.Acta Neuropathol2020
30827635Food authentication: Multi-elemental analysis of white asparagus for provenance discrimination.Food Chem2019
30183078Proteogenomic systems analysis identifies targeted therapy resistance mechanisms in EGFR-mutated lung cancer.Int J Cancer2019
31437373Immunohistochemical analysis of Bcl-2, nuclear S100A4, MITF and Ki67 for risk stratification of early-stage melanoma - A combined IHC score for melanoma risk stratification.J Dtsch Dermatol Ges2019
31266783Immunologic Profiling of Mutational and Transcriptional Subgroups in Pediatric and Adult High-Grade Gliomas.Cancer Immunol Res2019
31511427Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases.Sci Transl Med2019
30830316TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastoma.Acta Neuropathol2019
29061642Multilayered Omics-Based Analysis of a Head and Neck Cancer Model of Cisplatin Resistance Reveals Intratumoral Heterogeneity and Treatment-Induced Clonal Selection.Clin Cancer Res2018
29990622Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning.Semin Cancer Biol2018
30228931Subgroup-specific immune and stromal microenvironment in medulloblastoma.Oncoimmunology2018
30301811Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL.Blood Adv2018
27438523Tubular, lactating, and ductal adenomas are devoid of MED12 Exon2 mutations, and ductal adenomas show recurrent mutations in GNAS and the PI3K-AKT pathway.Genes Chromosomes Cancer2017
28405504PD-L1 (CD274) copy number gain, expression, and immune cell infiltration as candidate predictors for response to immune checkpoint inhibitors in soft-tissue sarcoma.Oncoimmunology2017
28466543Mutation patterns in genes encoding interferon signaling and antigen presentation: A pan-cancer survey with implications for the use of immune checkpoint inhibitors.Genes Chromosomes Cancer2017
27106868Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) - associations with gene expression, mutational load, and survival.Genes Chromosomes Cancer2016
26625204Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma.Oncotarget2016
26493284Mutations in genes encoding PI3K-AKT and MAPK signaling define anogenital papillary hidradenoma.Genes Chromosomes Cancer2016
25402435The landscape of metastatic progression patterns across major human cancers.Oncotarget2015
27499907Classical pathology and mutational load of breast cancer - integration of two worlds.J Pathol Clin Res2015
25480372Semiconductor sequencing: how many flows do you need?Bioinformatics2015
23945349New network topology approaches reveal differential correlation patterns in breast cancer.BMC Syst Biol2013
  • 1 - 40 of 40

Recommended Authors

Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 2016
Number of shared co-authors 0
Career Start Year 2015
Number of shared co-authors 3
The Hong Kong University of Science and Technology
Career Start Year 2012
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 0
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 0
School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo
Career Start Year 2008
Number of shared co-authors 0
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 0
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 1
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 5
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 0
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 5
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2006
Number of shared co-authors 9
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 0
Graduate School of Medicine, The University of Tokyo
Career Start Year 2005
Number of shared co-authors 0
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 3
Yale School of Medicine
Career Start Year 2004
Number of shared co-authors 6
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 2004
Number of shared co-authors 2
Washington University
Career Start Year 2003
Number of shared co-authors 2
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 2
Henry Ford Hospital
Career Start Year 2003
Number of shared co-authors 1
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 2
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 3
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Career Start Year 2001
Number of shared co-authors 1
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 0
Monash University
Career Start Year 2000
Number of shared co-authors 1
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 2000
Number of shared co-authors 1
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 0
Cleveland Clinic.
Career Start Year 1994
Number of shared co-authors 4
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 0
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 0

Collaborators

Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Co-authored papers 24
University Medical Center Hamburg-Eppendorf
Co-authored papers 15
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 12
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 9
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Co-authored papers 7
University Medical Center Hamburg-Eppendorf
Co-authored papers 6
Charite University Medicine Berlin
Co-authored papers 6
Massachusetts General Hospital/Harvard Medical School
Co-authored papers 5
Co-authored papers 5
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 5
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 5
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 4
Google Research
Co-authored papers 4
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 4
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 4
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Co-authored papers 3
Co-authored papers 3
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 3
Co-authored papers 3
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 3
Co-authored papers 3
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 2
Institute of Pathology, Charite Universitatsmedizin Berlin
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 2